PRKAA1 and obesity due to melanocortin 4 receptor deficiency: Given the well-known role of AMPK as a metabolic sensor and its involvement in the inflammatory response and IR in obesity, it is possible that the improvement of these metabolic outcomes after RYGB is mediated by alterations in AMPK activity and downstream molecular pathways.